$IPGP

SCHERBAKOV EUGENE A sold $132K of IPGP

SCHERBAKOV EUGENE A sold 1,524 shares of IPG PHOTONICS CORP (IPGP) at an average of $86.61 ($85.72–$88.68, $0.13M total) across 4 trades on 2026-07-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SCHERBAKOV EUGENE A
Published Aug 4, 2026, 8:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IPGP
Neutral
medium confidence
Mentioned
$IPGP
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPGPNeutralLow
01

Why it matters

The newest information is the specific open-market sale details (shares, price range, total value) and confirmation that it was executed under a pre-arranged Rule 10b5-1 plan.

02

Market read

This provides a fresh insider-selling datapoint for IPGP, but the 10b5-1 structure limits interpretive value for near-term fundamentals.

03

What to watch

Traders should check whether there are multiple consecutive insider sales, changes in total insider ownership, or concurrent company-specific catalysts (earnings, guidance, contracts) that could make the timing more meaningful.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-04 after-hours; reflects trades dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for IPG Photonics, reported by a director and 10% owner.

Company-level read

Ticker impact

$IPGPNeutralMedium confidence
Context

IPG Photonics disclosed a director and 10% owner open-market sale of 1,524 shares on 2026-07-31 under a 10b5-1 plan.

Expected impact

Low near-term impact; any move is likely sentiment-driven and should fade unless follow-on selling or other news appears.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling. The disclosed size ($131,993.64) is modest relative to a large-cap’s typical trading flow.

Market effects

No clear sector read-through; this is company-specific insider activity.

None.

None.

Counterpoint

Because the sale is under a 10b5-1 plan, it may be routine liquidity management rather than a bearish signal.

Key entities

  • IPG PHOTONICS CORP

    US-listed company whose insider transaction was disclosed on Form 4.

  • SCHERBAKOV EUGENE A

    Director and 10% owner who sold 1,524 shares across four trades on 2026-07-31 under a 10b5-1 plan.

Related articles

$IPGPMedAI 8/10

Why IPG Photonics Rallied Today

IPG Photonics (IPGP) shares rose 7.9% after the company reported mixed Q2 results and issued stronger-than-expected guidance. Revenue rose 11.1% to $278.6M, missing estimates, while adjusted EPS nearly doubled to $0.58. For Q3, IPG guided $280M revenue and $0.45 adjusted EPS at the midpoint.

$IPGPMed

IPG Photonics Q2 Earnings Call Highlights

IPG Photonics (IPGP) reported Q2 GAAP gross margin of 40.4% and adjusted gross margin of 40.7%, with GAAP diluted EPS of $0.12 and adjusted diluted EPS of $0.58. Management cited battery-manufacturing wins, additive manufacturing growth, and semiconductor momentum, plus CROSSBOW shipments for Lockheed Martin. IPG agreed to acquire Lumibird Medical, expected to close Q4 2026. Q3 revenue guidance is $265M to $295M.